Arzeda in the News

Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design

Oversubscribed financing will expand capacity and accelerate commercialization of products developed with Arzeda’s technology SEATTLE, (November 28, 2017) Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. The company raised an additional $3.2 million since announcing an initial $12 million

READ MORE

Biofuels Digest Ranks Arzeda #6 in Annual Hottest Companies in Bioeconomy List

Arzeda jumps 21 spots from last year in annual rankings of world’s most widely read biofuels and biobased chemicals daily journal SEATTLE (October 18, 2016)— Arzeda, the Protein Design CompanyTM, has once again been recognized among the top companies in the advanced bioeconomy in the annual rankings by Biofuels Digest, the world’s most widely read

READ MORE

Arzeda and TeselaGen Partner to Advance Biodesign Technologies for Industrial Biotechnology

SEATTLE and SAN FRANCISCO – (October 3, 2017) –Arzeda Corp, “The Protein Design Company™,” and TeselaGen Biotechnology Inc., a software company providing automated DNA design solutions with it’s Synthetic Evolution™ software platform, today announced that Arzeda will license TeselaGen’s proprietary cloud-based informatics solution and collaborate to extend TeselaGen’s state-of-the-art biological design automation platform. “TeselaGen’s industry-leading

READ MORE

Arzeda Raises $12 Million in Series A Round of Funding Led by OS Fund

Technology scale-up will unlock production of proteins that create sustainable stain-resistant paint, stronger Plexiglas, next-generation sweeteners, and purpose-built molecules that don’t yet exist SEATTLE, (July 20, 2017) Arzeda, The Protein Design Company™, today announced that it had raised $12 million in a Series A round of funding led by OS Fund and including Bioeconomy Capital

READ MORE

Biofuels Digest Names Arzeda Among Hottest Companies in Bioeconomy

Arzeda debuts in annual rankings of world’s most widely read biofuels and biobased chemicals daily journal   SEATTLE (November 7, 2016)— Arzeda, a synthetic biology company,  has been recognized among the top companies in the advanced bioeconomy in the annual rankings by Biofuels Digest, the world’s most widely read biofuels and biobased chemicals daily journal.

READ MORE

Arzeda produces 2 keystone molecules for Amyris-DARPA project

At ABLC Next in California, Arzeda reached a major technical milestone with Amyris as a part of a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement. Arzeda’s high-throughput, automated pipeline for protein engineering and pathway discovery has been validated by the production of two keystone molecules which will now be further optimized by Amyris.

READ MORE

Arzeda Scales High-throughput, Automated Molecule Development Pipeline

Creates industrial molecules that can be produced via fermentation to meet demand in commercial markets SEATTLE (November 3, 2016) Arzeda has reached a major technical milestone with Amyris, Inc. (Nasdaq:AMRS) as a part of a Defense Advanced Research Projects Agency (DARPA) Technology Investment Agreement (TIA). Arzeda’s high-throughput, automated pipeline for protein engineering and pathway discovery has

READ MORE

COMPUTATIONAL APPROACH STREAMLINES INDUSTRIAL ENZYME DEVELOPMENT

Computational technology from Arzeda Corp. (Seattle, Wash.; www.arzeda.com) can streamline the development of novel enzymes, as well as improve existing enzymes, for industrial fermentation. The company’s proprietary computational platform, known as Archytas, uses advanced algorithms to design and screen a vast number of DNA sequences that code for enzymes with properties desirable for a targeted

READ MORE

Synthetic Biology – The next renewables frontier?

Yes! The Green Chemicals Blog highlights some of the recent advances in Synthetic Biology- in particular, Arzeda’s positioning within the field and some of the recent announcements.

READ MORE

Renewables firms focus on cost squeeze

BIO conference attendees sought expertise, partners to help compete with fossil feedstocks   Last month’s gathering of the Biotechnology Innovation Organization’s World Congress on Industrial Biotechnology, held in San Diego, featured six tracks of diverse talks and panel discussions.

READ MORE

Designer Genes And The DNA To Make Them

Forbes “recently heard fascinating and synergistic “innovation stories” from the CEOs of two biotech companies.  One organization, Arzeda, uses computers to design genes for enzymes and pathways involving multiple enzymes.  The other, Gen9, specializes in making long strands of DNA very efficiently and accurately – in this case the DNA that codes for those “designer genes.”  At last

READ MORE

Gen9, Arzeda Ink Supply Agreement for Synthetic DNA

READ MORE

Gen9 and Arzeda Announce Supply Agreement for Synthetic DNA

Gen9 and Arzeda today announced an agreement for the supply of megabase quantities of synthetic DNA that will enable Arzeda to accelerate development of novel molecules for its own products as well as those of its partners. The collaboration is part of Gen9’s MAP program, designed to provide industrial users of synthetic DNA with access

READ MORE
Download PDF

Synthetic Biology for Chemical Production

Alexandre Zanghellini, Arzeda’s CEO, penned an overview of both the current and the future impact of synthetic biology upon the chemicals industry. It highlights the opportunities that can be opened through the simultaneous advance of several technologies- improved fermentation strategies, development of biological FABs, designer biocatalysts, and improved synthetic DNA. Arzeda is at the forefront

READ MORE

Business Roundup

Arzeda spotlight in C&EN’s news of the week.

READ MORE

Arzeda-Zymergen Collaboration covered by Chemical Engineering

Chemical Engineering, a premier industry journal for the chemical engineering field, highlighted Arzeda’s recent announcement of its partnership with Zymergen

READ MORE

Arzeda and Zymergen Collaborate on Development of New Molecules

SEATTLE and EMERYVILLE, Calif. (March 21, 2016) Zymergen and Arzeda announced today a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities. “The development of new materials was a major driver of technological development over the course of

READ MORE
Download PDF

INVISTA gets patent for engineered polypeptides

INVISTA collaborated with Arzeda to develop the innovations covered by the patent, which was issued on Dec. 29, 2015.

READ MORE

Business Roundup

Arzeda’s technolgoy and its partnership with Mitsubishi Rayon are highlighted

READ MORE

Mitsubishi Rayon and Arzeda Collaborate on Development of New Processes for Industrial Chemicals Production

“Through our own experience and expertise, as well as with innovative technology like Arzeda’s, Mitsubishi Rayon can meet the growing global demand for a range of products in a sustainable manner,” said Takayuki Iseki, General Manager, R&D Administration Department. “We look forward to the collaboration.”

READ MORE
Download PDF

Designer Enzymes and Strains: The Digest’s 2016 Guide to Arzeda

100,000+ naturally occurring molecules are known but the biosynthesis is unknown — and cannot be made economically at any scale, today. Meanwhile, millions of synthetic non-natural molecules that could be made with designed enzymes and new metabolic pathways. And this means superior properties not accessible with “natural” biology nor synthetic chemistry. That’s the Arzeda vision, as detailed

READ MORE

Plug-and play synthbio: Arzeda, INVISTA, others finding new pathways to affordable, everyday materials

“…That’s where companies like Arzeda come in — specializing in developing novel ‘pathways’, which is to say, a prized material that the magic bug didn’t know how to make before…”

READ MORE

INVISTA receives patent for bio-derived raw materials technology developed through collaboration with Arzeda

…Alexandre Zanghellini, co-founder and chief executive officer at Arzeda, said, “The issuance of this patent is yet another example of the power of combining Arzeda’s computational protein design technology Archytas™ with experimental screening to rapidly design synthetic enzymes. With INVISTA’s expertise in biotechnology and industrial scale-up, we are confident this collaboration will lead to advanced

READ MORE
Download PDF

Those Pesky Petrochemicals – Is There a Better Way?

“…entered into collaboration with Arzeda, a biotech company that ‘creates innovative cell factories that can transform or supplement current chemical production methods.’”

READ MORE

Arzeda Agreement with Stratos Genomics for Novel Enzyme Development

Arzeda will help further develop Stratos’ “Sequencing by Design” technology for rapid single molecule DNA sequencing SEATTLE, November 11, 2015 – Biotechnology company Arzeda announced today an Agreement with Stratos Genomics to assist development of novel enzymes supporting Stratos’ DNA sequencing technology. Under the agreement, Arzeda will use its best-in-class enzyme engineering and pathway design technologies to

READ MORE
Download PDF

synbiobeta highlights – Bugs Making Drugs

… Arzeda
, which earlier signed an agreement to create novel seeds with DuPont, has turned its platform technology to creating specialty chemicals and pharma intermediates. Alex Zanghellini, the CEO will discuss the company’s journey thus far.

READ MORE

LEGO commits $150M to search for sustainable alternative plastics

…A number of players have jumped into the early stages of the race for renewable butadiene. Genomatica/Versalis are hot on the trail of butadiene, with LanzaTech/INVISTA, Arzeda/INVISTA and Global Bioenergies/Synthos….

READ MORE

Arzeda and SGI-DNA Pair In Silico and DNA Technologies To Build A Better Enzyme Design Pipeline

(SEATTLE, WA AND LA JOLLA, CA) – June 17, 2015 – Seattle-based Arzeda Corporation recently implemented the BioXp™ 3200 System from SGI-DNA, allowing the biotechnology company to significantly shorten their enzyme design research cycles. Arzeda’s ability to quickly synthesize DNA fragments with SGI-DNA’s technology in house, as opposed to time-intensive outsourcing, means that the company

READ MORE
Download PDF

Arzeda awarded $1.2M for ARPA-E Transformational Energy Technology Program

WASHINGTON, DC–Deputy Director Cheryl Martin announced breakthrough energy projects which will receive approximately $66 million from the Advanced Research Projects Agency-Energy (ARPA-E) under two new programs that provide options for a more sustainable and secure American future. Deputy Director Martin made the project announcement during a roundtable discussion on Capitol Hill that focused on how

READ MORE

INVISTA and Arzeda enter agreement to develop bio-derived raw materials

WICHITA, Kan. and SEATTLE – Feb. 6, 2013 – INVISTA Technologies S.à r.l. and Arzeda Corp. announce a collaboration for the development of new technologies to enable novel bio-derived processes. The agreement brings together complementary technologies: INVISTA’s capabilities in biotechnology and catalysis, and knowledge of the chemicals industry; and Arzeda’s unique synthetic biology and enzyme design capabilities. The

READ MORE
Download PDF

Technology Collaboration Reaches First Milestone

Seattle, December 30, 2010 – DuPont business Pioneer Hi-Bred and Arzeda Corporation have reached the first milestone in a technology collaboration to develop new traits to increase agriculture productivity. A novel enzyme developed by Arzeda is showing activity toward a trait of interest for two core crops for Pioneer – corn and soybean. This is another

READ MORE
Download PDF

ARZEDA Featured in Microsoft Case Study

SEATTLE, December 3, 2010 – Arzeda has been featured in a Microsoft Case Study to showcase its innovative use of cloud computing for solving challenging computational problem. Arzeda entered into a Microsoft TAP partnership in 2009 to adapt its computing infrastructure to Microsoft Cloud computing architecture, MS Azure. Arzeda’s software developers have teamed up with

READ MORE
Download PDF

ARZEDA Receives NSF SBIR Phase I Award

SEATTLE, December 8, 2009 – Arzeda Corp announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) phase I grant in the amount of $149K for the computational design and experimental validation of an enzyme for the production of butadiene, an important and widely-used chemical intermediate, from plants and

READ MORE
Download PDF

DuPont and Arzeda Collaborate to Develop Improved Crops to Increase Productivity

DES MOINES, Iowa, and SEATTLE, July 13, 2009 — DuPont and Arzeda Corp. today announced a technology collaboration to develop new traits to increase agricultural productivity. Under the agreement, DuPont business Pioneer Hi-Bred will use novel enzymes designed by Arzeda to develop next generation seed traits in crops of worldwide agricultural importance such as corn,

READ MORE
Download PDF

Building Enzymes from Scratch

In an undertaking so computationally demanding it required donated computer time from thousands of people around the world, Howard Hughes Medical Institute (HHMI) researchers have designed and built two functional enzymes never seen in nature. Howard Hughes Medical Institute, Research News: Building Enzymes from Scratch  

READ MORE

Synthetic enzymes designed by computer

Scientists in the US have designed and built an artificial enzyme from scratch. Their computer-based creation is a relatively feeble catalyst compared to natural enzymes, but the feat illustrates how new, bespoke enzymes might be designed for any chemical reaction, providing their efficiency can be improved. Chemistry World News: Synthetic Enzymes Designed by Computer

READ MORE